Drug Safety / Pharmacovigilance 

Government   

Websites:    

• Health Canada Online
  • Drugs and Health Products 
  • Canadian Adverse Drug Reaction Newsletter (CARN)
  • Expert Advisory Committee on Pharmacovigilance
• U.S. Food and Drug Administration (FDA)
  • Center for Drug Evaluation and Research (CDER)
  • Medication Guides
  • MedWatch: The FDA Medical Products Reporting Program
• Agency for Healthcare Research and Quality (AHRQ)
  • Medical Errors and Patient Safety
• Medicines and Healthcare Products Regulatory Agency (MHRA)
  • Committee on Safety of Medicines (CSM)
  • Current Problems in Pharmacovigilance
  • Safety Information
• The Uppsala Monitoring Centre (UMC) (The WHO Collaborating Centre for International Drug Monitoring)
  • Adverse Reaction (ADR) Newsletter (Beginning in the year 2000, this newsletter was incorporated in the WHO Pharmaceutical Newsletter)
  • WHO Pharmaceuticals Newsletter
• European Medicines Agency (EMEA)
• Australian Government: Therapeutic Goods Administration (TGA)
  • Australian Adverse Drug Reactions Bulletin
• France Ministry of Health
  • Agence Francaise de Securite Sanitaire des Produits de Sante (French Medicines Agency)
• Germany Federal Institute for Drugs and Medical Devices (BfArM)
• New Zealand Medicines and Medical Devices Safety Authority (MEDSAFE)
• Swedish Medical Products Agency

   Organizations

Websites:   

• Institute for Safe Medication Practice (ISMP- Canada)
• Institute for Safe Medication Practice (ISMP- US)
• USP (United States Pharmacopeia)
• Institute of Medicine (IOM) of the National Academies
• National Quality Forum (NQF)
• National Patient Safety Foundation (NPSF)
• Health Action International (HAI)
• International Society for Pharmacoepidemiology (ISPE)
• U.K. Drug Safety Research Unit (DSRU)

Recommended texts are linked to publishers' or book sellers' websites for further ordering information:   

• Dictionary of Pharmacovigilance (Alghabban 2004) - $

Dynamic Searches:   

Please follow these links to search PubMed for the latest:

• Citations in which the MeSH for drug safety – Drug Toxicity – is combined using AND with either the textword pharmacovigilance or the textword phrase “drug safety”.
• Citations in which the textword pharmacovigilance or the textword phrase “drug safety” appear in journal article titles.
• Citations in which the MeSH  - Adverse Drug Reaction Reporting Systems - is a major concept.
• Citations in which the MeSH for post-marketing surveillance – Product Surveillance, Postmarketing – is a major concept.
  

 $ - Resource is not freely available on the Internet